PuSH - Publikationsserver des Helmholtz Zentrums München

Chen, J. ; Wang, X. ; Schmalen, A. ; Haines, S. ; Wolff, M.* ; Ma, H.* ; Zhang, H.* ; Stoleriu, M.-G. ; Nowak, J. ; Nakayama, M. ; Bueno, M.* ; Brands, J.* ; Mora, A.L.* ; Lee, J.S.* ; Krauss-Etschmann, S.* ; Dmitrieva, A. ; Frankenberger, M. ; Hofer, T.P. ; Nößner, E. ; Moosmann, A.* ; Behr, J.* ; Milger, K.* ; Deeg, C.A.* ; Staab-Weijnitz, C.A. ; Hauck, S.M. ; Adler, H. ; Goldmann, T.* ; Gaede, K.I.* ; Behrends, J.* ; Kammerl, I.E. ; Meiners, S.

Antiviral CD8+T-cell immune responses are impaired by cigarette smoke and in COPD.

Eur. Respir. J. 62:16 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Background Virus infections drive COPD exacerbations and progression. Antiviral immunity centres on the activation of virus-specific CD8+ T-cells by viral epitopes presented on major histocompatibility complex (MHC) class I molecules of infected cells. These epitopes are generated by the immunoproteasome, a specialised intracellular protein degradation machine, which is induced by antiviral cytokines in infected cells. Methods We analysed the effects of cigarette smoke on cytokine-and virus-mediated induction of the immunoproteasome in vitro, ex vivo and in vivo using RNA and Western blot analyses. CD8+ T-cell activation was determined in co-culture assays with cigarette smoke-exposed influenza A virus (IAV)-infected cells. Mass-spectrometry-based analysis of MHC class I-bound peptides uncovered the effects of cigarette smoke on inflammatory antigen presentation in lung cells. IAV-specific CD8+ T-cell numbers were determined in patients peripheral blood using tetramer technology. Results Cigarette smoke impaired the induction of the immunoproteasome by cytokine signalling and viral infection in lung cells in vitro, ex vivo and in vivo. In addition, cigarette smoke altered the peptide repertoire of antigens presented on MHC class I molecules under inflammatory conditions. Importantly, MHC class I-mediated activation of IAV-specific CD8+ T-cells was dampened by cigarette smoke. COPD patients exhibited reduced numbers of circulating IAV-specific CD8+ T-cells compared to healthy controls and asthmatics. Conclusion Our data indicate that cigarette smoke interferes with MHC class I antigen generation and presentation and thereby contributes to impaired activation of CD8+ T-cells upon virus infection. This adds important mechanistic insight on how cigarette smoke mediates increased susceptibility of smokers and COPD patients to viral infections.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
24.300
3.602
1
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Obstructive Pulmonary-disease; Acute Exacerbations; Proteasome Function; I Interferon; Exposure; Virus; Pathogenesis; Increases; Severity; Insights
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 0903-1936
e-ISSN 1399-3003
Quellenangaben Band: 62, Heft: 2, Seiten: , Artikelnummer: 16 Supplement: ,
Verlag European Respiratory Society
Verlagsort Sheffield
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
80000 - German Center for Lung Research
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Lung Research
Enabling and Novel Technologies
Allergy
Immune Response and Infection
PSP-Element(e) G-501600-004
G-501800-816
G-505700-001
G-501600-001
G-503300-001
G-501600-012
G-502710-001
G-501800-817
A-630700-001
Förderungen Leibniz foundation
Shiga University of Medical Science
Uehara Memorial Foundation
China Postdoctoral Science Foundation
National Natural Science Foundation of China
German Federal Ministry of Education and Research, Germany (BMBF) grant EXASENS
Helmholtz Center Munich
European Respiratory Society (ERS)
Faculty of Medicine at LMU
Scopus ID 85166479840
PubMed ID 37385655
Erfassungsdatum 2023-10-18